The kynurenine pathway and the brain: Challenges, controversies and promises

R Schwarcz, TW Stone - Neuropharmacology, 2017 - Elsevier
Research on the neurobiology of the kynurenine pathway has suffered years of relative
obscurity because tryptophan degradation, and its involvement in both physiology and major …

Does kynurenic acid act on nicotinic receptors? An assessment of the evidence

TW Stone - Journal of neurochemistry, 2020 - Wiley Online Library
As a major metabolite of kynurenine in the oxidative metabolism of tryptophan, kynurenic
acid is of considerable biological and clinical importance as an endogenous antagonist of …

Natural products modulating the hERG channel: heartaches and hope

JM Kratz, U Grienke, O Scheel, SA Mann… - Natural product …, 2017 - pubs.rsc.org
Covering: 1996–December 2016 The human Ether-à-go-go Related Gene (hERG) channel
is a voltage-gated potassium channel playing an essential role in the normal electrical …

QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine

K Malone, JC Hancox - Therapeutic Advances in Drug …, 2020 - journals.sagepub.com
Background: Acetylcholinesterase inhibitors (AChEis) including donepezil, galantamine and
rivastigmine are used to treat Alzheimer's disease (AD). This study aimed to evaluate …

Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias–A narrative review

Y Huang, MW Alsabbagh - Pharmacology Research & …, 2020 - Wiley Online Library
Donepezil, galantamine, and rivastigmine are the three acetylcholinesterase inhibitors
(AChEIs), out of a total of only four medications prescribed in the treatment of Alzheimer's …

Proarrhythmic effect of acetylcholine-esterase inhibitors used in the treatment of Alzheimer's disease: benefit of rivastigmine in an experimental whole-heart model

C Ellermann, A Coenen, P Niehues, P Leitz… - Cardiovascular …, 2020 - Springer
Several studies suggest QT prolongation and torsade de pointes with acetylcholine-esterase
inhibitors. We therefore examined the electrophysiologic profile of donepezil, rivastigmine …

Effects of donepezil on hERG potassium channels

YJ Chae, HJ Lee, JH Jeon, IB Kim, JS Choi, KW Sung… - Brain Research, 2015 - Elsevier
Donepezil is a potent, selective inhibitor of acetylcholinesterase, which is used for the
treatment of Alzheimer's disease. Whole-cell patch-clamp technique and Western blot …

Cholinesterase inhibitors-associated torsade de pointes/QT prolongation: a real-world pharmacovigilance study

N Zhang, L Gan, G Xiang, J Xu, T Jiang, Y Li… - Frontiers in …, 2024 - frontiersin.org
Objective: Cholinesterase inhibitor (ChEIs) is the first-line drug for Alzheimer's disease (AD).
Understanding torsade de pointes (TdP)/QT prolongation with different ChEIs is essential for …

Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes

W Froestl, A Muhs, A Pfeifer - Journal of Alzheimer's Disease, 2013 - content.iospress.com
Cognitive enhancers (nootropics) are drugs to treat cognition deficits in patients suffering
from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or …

Natural products as potential human ether-a-go-go-related gene channel inhibitors–screening of plant-derived alkaloids

A Schramm, P Saxena, J Chlebek, L Cahlíková… - Planta …, 2014 - thieme-connect.com
Inhibition of the cardiac human ether-a-go-go-related gene channel is a problematic off-
target pharmacological activity and, hence, a major safety liability in clinical practice. Several …